Published in Ann Med on August 24, 2011
Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study. Arthritis Res Ther (2014) 0.99
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med (2013) 7.76
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (2007) 5.41
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med (2010) 5.06
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA (2006) 4.75
Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med (2013) 4.43
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA (2004) 3.55
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation (2007) 3.20
Bidirectional relation between inflammation and coagulation. Circulation (2004) 3.00
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet (2003) 2.86
The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis. J Am Coll Cardiol (2003) 2.71
Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ (2012) 2.38
Comparing the diagnostic performance of 2 clinical decision rules to rule out deep vein thrombosis in primary care patients. Ann Fam Med (2011) 2.34
Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review. Ann Intern Med (2003) 2.33
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Arch Intern Med (2003) 2.33
The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol (2005) 2.31
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med (2011) 2.28
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med (2002) 2.16
Direct thrombin inhibitors. N Engl J Med (2005) 2.15
Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J (2012) 2.08
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res (2006) 1.95
Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med (2004) 1.92
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med (2005) 1.82
Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study. Arch Intern Med (2002) 1.81
Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. Blood (2011) 1.63
Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J (2013) 1.58
Cardiovascular risk assessment in haemophilia patients. Thromb Haemost (2010) 1.57
Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest (2013) 1.55
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med (2008) 1.54
Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb Haemost (2009) 1.51
Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood (2013) 1.51
Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation (2010) 1.50
Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med (2003) 1.49
Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med (2014) 1.42
Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia. Thromb Haemost (2012) 1.40
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran. Thromb Haemost (2015) 1.36
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet (2002) 1.32
A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk. PLoS Med (2005) 1.20
Guidelines were developed for data collection from medical records for use in retrospective analyses. J Clin Epidemiol (2005) 1.20
Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab (2009) 1.17
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res (2009) 1.17
Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism. Haematologica (2002) 1.16
Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med (2002) 1.14
Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost (2005) 1.14
Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis (2005) 1.14
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation (2002) 1.13
The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. Chest (2007) 1.12
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy. AIDS Patient Care STDS (2009) 1.11
Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med (2002) 1.09
Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol (2009) 1.08
Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J (2009) 1.08
Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg (2004) 1.05
Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res (2010) 1.04
Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost (2012) 1.04
Travel and the risk of symptomatic venous thromboembolism. Thromb Haemost (2003) 1.03
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost (2007) 1.01
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood (2008) 1.01
Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol (2006) 1.00
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica (2012) 1.00
Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol (2012) 0.99
Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS One (2012) 0.96
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood (2010) 0.96
Acute pulmonary embolism. Part 2: treatment. Nat Rev Cardiol (2010) 0.96
Idiopathic superficial thrombophlebitis and the incidence of cancer in primary care patients. Ann Fam Med (2010) 0.95
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol (2014) 0.95
Estimates of risk of venous thrombosis during pregnancy and puerperium are not influenced by diagnostic suspicion and referral basis. Am J Obstet Gynecol (2004) 0.95
Secondary prophylaxis with warfarin for venous thromboembolism. N Engl J Med (2003) 0.95
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. Thromb Res (2013) 0.95
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis. Intensive Care Med (2003) 0.94
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. Thromb Haemost (2009) 0.94
Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule. Br J Gen Pract (2006) 0.93
Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg (2005) 0.92
The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor. Thromb Haemost (2002) 0.92
Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome. Chest (2012) 0.91
Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study of 335 patients. Acta Orthop (2006) 0.91
Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med (2004) 0.91
The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. PLoS Med (2007) 0.91
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica (2005) 0.91
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. J Hepatol (2013) 0.90